Related Experiment Videos
Genetic biomarkers for migraine
Boukje De Vries1, Joost Haan, Rune R Frants
1Department of Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
Headache
|July 27, 2006
Summary
Genetic biomarkers offer potential for diagnosing and treating migraine. While few are currently established, research into genetic variations like MTHFR C677T shows promise for understanding migraine susceptibility and response.
Area of Science:
- Neurology
- Genetics
- Biomarker Research
Background:
- Biomarkers are crucial for diagnosing and understanding diseases.
- In migraine, clinical, radiological, and biochemical markers aid diagnosis and treatment.
- Genetic biomarkers, variations predicting susceptibility or treatment response, are emerging in migraine research.
Purpose of the Study:
- To review the current state of genetic biomarkers in migraine.
- To discuss their potential diagnostic and prognostic utility.
- To highlight examples and limitations of genetic markers in migraine.
Main Methods:
- Review of existing literature on genetic biomarkers for migraine.
- Analysis of genetic variations associated with familial hemiplegic migraine and common migraine forms.
- Evaluation of findings from linkage and association studies.
Main Results:
- Few genetic biomarkers for migraine are currently clinically established.
- Mutations in three genes for familial hemiplegic migraine are identified.
- The MTHFR C677T polymorphism is a known genetic marker for common migraine.
- Many findings from association studies lack replication and clinical utility.
Conclusions:
- Genetic biomarkers hold promise for advancing migraine diagnosis and treatment.
- Further research and replication are needed to establish reliable genetic markers for common migraine.
- Understanding genetic variations is key to personalized migraine management.